Pfizer, Allergan scrap $160 billion deal after US tax rule change - Reuters
| Reuters | Pfizer, Allergan scrap $160 billion deal after US tax rule change Reuters U.S. drugmaker Pfizer Inc and Ireland-based Allergan Plc walked away from their $160 billion merger on Wednesday, a major win for President Barack Obama, who has been pushing to curb deals in which companies move overseas to save on taxes. Pfizer and Allergan Call Off Merger Pfizer and Allergan call off their $160 billion merger after US move to block inversions $160 billion Pfizer, Allergan inversion scrapped |